BIOHIT BEGINS TEST MARKETING OF ITS XYLICYST CHEWING GUM
Biohit Oyj has begun to test market the XyliCyst chewing gum, a functional food
product, through an online shop (www.verkkoapteekki.fi). At this stage, it is
difficult to estimate the impact of this test marketing on the total net sales
of the Biohit Group in 2007.
Verkkoapteekki.fi is a Finnish online shop selling health care products and
articles via Internet.
The XyliCyst chewing gum eliminates acetaldehyde that dissolves in saliva during
tobacco smoking. Research studies have shown that acetaldehyde is a major risk
factor for cancers of the upper gastrointestinal tract and that it may increase
addiction to tobacco products. XyliCyst is developed and marketed by Biohit and
manufactured by Fennobon Oy.
Biohit Oyj
Osmo Suovaniemi
President & CEO
Further information:
Osmo Suovaniemi, M.D., Ph.D., Professor
President & CEO
Tel: +358-9-773 861
Mobile: +358-40-745 5605
Email: osmo.suovaniemi@biohit.com
Distribution:
Helsinki Exchanges
Financial Supervisory Authority
Press
http://www.biohit.com